But Dr. Joseph McGowan, HIV services medical director at Northwell Health ... which tests people like those seeking treatment ...

The treatment worked so well that her tumor shrank by more than ... and in four the volume of tumors were reduced by at least ...

Gilead (GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention treatment lenacapavir ...

More (and smarter) prevention: One of the amazing things about Ryan White (the young hero and the landmark HIV legislation he ...

From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...

Data from a phase Ia clinical trial of an oral, long-acting integrase inhibitor (GS-1720) in development for HIV demonstrated ...

Recent health data reveals an alarming rise in HIV transmission rate between older men and young women, presenting a complex ...

Overall, the HIV treatment market continues to grow in line with our expectations ... We'll be sharing updated data at the ASH conference and look forward to potentially offering Anito-cel’s ...

As part of our coverage of the biennial AIDS conference from the International AIDS Society, we spoke with Madalitso Juwayeyi, program manager at FACT-Malawi, to learn more about her organization and ...

These drugs may help prevent HIV transmission. If you received a diagnosis of HIV, carefully following your treatment plan is ...

If you notice these symptoms, especially if you’ve recently engaged in behaviors that increase your risk of getting an HIV ...

Gilead Sciences' Q3 2024 results exceeded expectations, driven by a strong performance of the HIV portfolio. Read why I ...